Feed JAGX
JA

Jaguar Health JAGX · NASDAQ

$2.04 -5.12% (-$0.11)

Market cap
$4.18M
Enterprise value
$17.0M
P/E
-
Forward P/E
-
PEG
-
P/S
0.2x
P/FCF
-
EV/EBITDA
-
ROIC
-118.2%
Gross margin
82.3%
Net margin
-132.0%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-
Beta
-0.06
Free float
93.8%

About the company

Jaguar Health, Inc. (JAGX) is an American company focused on researching, developing, and commercializing pharmaceuticals and natural medicines for veterinary and human health. The company specializes in treating various gastrointestinal disorders, such as diarrhea and other digestive issues, in both animals and humans. Jaguar Health aims to utilize natural resources and innovative technologies to develop safe and effective therapeutic solutions. The company also has research projects focused on the prevention and treatment of other health conditions. Shares of Jaguar Health, Inc. (JAGX) can represent an interesting investment opportunity for investors who follow innovations in healthcare and pharmaceuticals and seek investments in the biotechnology sector.

Sector

Healthcare

Industry

Biotechnology

CEO

Lisa A. Conte

Employees

47

Headquarters

San Francisco

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy